EUVIMEDEUVIMED entdecken
Multizentrische Studie

Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort

Johannes Wiegand iD, Annegret Franke, Tobias Müller, Kerstin Stein, Heike Bantel, Rainer Günther, Gerald Denk, Philipp A Reuken iD, Jörn M Schattenberg, Uwe Naumann, Tobias Böttler, Andreas Weber und 26 weitere

Zeitschrift für Gastroenterologie · 01.11.2024 · 62 (11) · 1931-1942

DOI: 10.1055/a-2382-7720 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.11.2024. Verfasst von Johannes Wiegand und 37 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatology, Department of Medicine II, University Medical Centre, Leipzig, Germany. Hauptthemen laut MEDLINE: Ursodeoxycholic Acid, Liver Cirrhosis, Biliary, Registries. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Real-world data on the management of patients with primary biliary cholangitis (PBC) are so far scarce in Germany. Therefore, we aimed to establish a nationwide registry and describe the clinical characteristics and therapy of PBC patients. Three different cohorts defined as ursodeoxycholic acid (UDCA) responders, as inadequate responders according to Paris II criteria, and as newly diagnosed patients were prospectively recruited. This manuscript includes the baseline data of the project. In total, 33/77 (43%) contacted centres (58% of university hospitals, 38% of non-university hospitals, and 24% of private practices) recruited 515 patients including 204 UDCA responders, 221 inadequate responders to UDCA, and 90 newly diagnosed patients. All patients were treated with UDCA; however, a UDCA dosage below the recommended dosage of 13 mg/kg/d was observed in 38.5% of individuals after 12 months of treatment. UDCA dosages were lower in nonacademic compared to academic centres. Only 75/219 (38.5%) of inadequate responders to UDCA received a second-line therapy with obeticholic acid (OCA) and/or bezafibrate (BZF). OCA (13% vs. 4.5%) and BZF (14% vs. 6.5%) were significantly more often prescribed by academic vs. nonacademic centres. Pruritus (27% vs. 15.5%), fatigue (23% vs. 4.5%), and sicca syndrome (14% vs. 1%) were significantly more often reported by academic centres. The German PBC registry could be established, which indicates suboptimal therapy in a relevant proportion of patients and shows significant differences between academic and nonacademic centres. Results are fundamental to improving clinical management at different levels of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ursodeoxycholic AcidLiver Cirrhosis, BiliaryRegistriesHumansGermanyMaleFemaleMiddle AgedAgedCohort StudiesTreatment OutcomeDose-Response Relationship, DrugPrevalenceRisk FactorsCholagogues and CholereticsChenodeoxycholic AcidBezafibrateComorbidityAdult

Substanzen

Ursodeoxycholic AcidCholagogues and CholereticsChenodeoxycholic AcidBezafibrateobeticholic acid

Autor:innen und Institutionen

  • Division of Hepatology, Department of Medicine II, University Medical Centre, Leipzig, Germany.
  • Clinical Trial Centre of Medical Faculty, University of Leipzig, Leipzig, Germany.
  • Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Practice of Hepatology Magdeburg, Magdeburg, Germany.
  • Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Division of Hepatology, Department of Medicine I, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.

ORCID-Profile: Johannes Wiegand, Philipp A Reuken, Robin Greinert, Jonel Trebicka, Jens U Marquardt

Zitieren

APA

Wiegand, J., Franke, A., Müller, T., Stein, K., Bantel, H., Günther, R., Denk, G., Reuken, P. A., Schattenberg, J. M., Naumann, U., Böttler, T., Weber, A., Zeuzem, S., Hinz, M., Greinert, R., Berg, C., Wissniowski, T. T., Simon, K. G., Trebicka, J., …, & Berg, T. (2024). Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort. Zeitschrift für Gastroenterologie, 62(11), 1931-1942. https://doi.org/10.1055/a-2382-7720

Vancouver

Wiegand J, Franke A, Müller T, Stein K, Bantel H, Günther R, et al. Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort. Zeitschrift für Gastroenterologie. 2024;62(11):1931-1942. doi:10.1055/a-2382-7720

BibTeX
@article{Wiegand2024,
  author = {Wiegand, Johannes and Franke, Annegret and Müller, Tobias and Stein, Kerstin and Bantel, Heike and Günther, Rainer and Denk, Gerald and Reuken, Philipp A and Schattenberg, Jörn M and Naumann, Uwe and Böttler, Tobias and Weber, Andreas and Zeuzem, Stefan and Hinz, Matthias and Greinert, Robin and Berg, Christoph and Wissniowski, Thaddäus Till and Simon, Karl-Georg and Trebicka, Jonel and Behrens, Rüdiger and Grümmer, Harald and Hofmann, Wolf Peter and Dikopoulos, Nektarios and Sarrazin, Christoph and Roeb, Elke and Kremer, Andreas E and Muche, Marion and Ringelhan, Marc and Teufel, Andreas and Michl, Patrick and Keitel, Verena and Marquardt, Jens U and Kautz, Achim and Tacke, Frank and Piotrowski, Katja and Köppe-Bauernfeind, Nicole and Trautwein, Christian and Berg, Thomas},
  title = {Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {11},
  pages = {1931--1942},
  doi = {10.1055/a-2382-7720}
}
Kostenlos starten →